Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Depreciation and Depletion (2021 - 2025)

Oncology Institute (TOI) has disclosed Depreciation and Depletion for 5 consecutive years, with $1.0 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Depreciation and Depletion rose 25.75% year-over-year to $1.0 million, compared with a TTM value of $4.0 million through Sep 2025, up 29.76%, and an annual FY2024 reading of $3.2 million, up 11.45% over the prior year.
  • Depreciation and Depletion was $1.0 million for Q3 2025 at Oncology Institute, down from $1.0 million in the prior quarter.
  • Across five years, Depreciation and Depletion topped out at $1.0 million in Q2 2025 and bottomed at $165000.0 in Q1 2021.
  • Average Depreciation and Depletion over 5 years is $603000.0, with a median of $601000.0 recorded in 2023.
  • The sharpest move saw Depreciation and Depletion soared 132.57% in 2023, then dropped 12.47% in 2024.
  • Year by year, Depreciation and Depletion stood at $263000.0 in 2021, then soared by 74.9% to $460000.0 in 2022, then soared by 75.65% to $808000.0 in 2023, then grew by 15.47% to $933000.0 in 2024, then grew by 7.82% to $1.0 million in 2025.
  • Business Quant data shows Depreciation and Depletion for TOI at $1.0 million in Q3 2025, $1.0 million in Q2 2025, and $1.0 million in Q1 2025.